GAPDH-mediated posttranscriptional regulations of sodium channel Scn1a and Scn3a genes under seizure and ketogenic diet conditions

Neuropharmacology

Volumn 113, Issue , 2017, Pages 480-489

  Lin, Guo Wang ^a   Lu, Ping ^a   Zeng, Tao ^a   Tang, Hui Ling ^a   Chen, Yong Hong ^a   Liu, Shu Jing ^a   Gao, Mei Mei ^a   Zhao, Qi Hua ^a   Yi, Yong Hong ^a   Long, Yue Sheng ^a  

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Glyceraldehyde 3 phosphate dehydrogenase; Ketogenic diet; Posttranscriptional regulation; Seizure; Sodium channel

Indexed keywords

3 HYDROXYBUTYRIC ACID; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; MESSENGER RNA; PROTEIN BINDING; SCN1A PROTEIN, HUMAN; SCN3A PROTEIN, HUMAN; SODIUM CHANNEL; SODIUM CHANNEL NAV1.1; SODIUM CHANNEL NAV1.3;

3' UNTRANSLATED REGION; ANIMAL CELL; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; KETOGENIC DIET; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; RNA STABILITY; SCN1A GENE; SCN3A GENE; SEIZURE; THERAPY EFFECT; UPREGULATION; ANIMAL; BIOSYNTHESIS; DIET THERAPY; GENETICS; HEK293 CELL LINE; MALE; METABOLISM; PHYSIOLOGY; PROCEDURES; RNA PROCESSING; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASES; HEK293 CELLS; HUMANS; KETOGENIC DIET; MALE; MICE; NAV1.1 VOLTAGE-GATED SODIUM CHANNEL; NAV1.3 VOLTAGE-GATED SODIUM CHANNEL; PROTEIN BINDING; RNA PROCESSING, POST-TRANSCRIPTIONAL; SEIZURES; SODIUM CHANNELS;

EID: 84994148925     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2016.11.002     Document Type: Article

References (51)

1. Backlund, M., Paukku, K., Daviet, L., De Boer, R.A., Valo, E., Hautaniemi, S., et al. Posttranscriptional regulation of angiotensin II type 1 receptor expression by glyceraldehyde 3-phosphate dehydrogenase. Nucleic Acids Res. 37 (2009), 2346–2358.
2. Beckh, S., Differential expression of sodium channel mRNAs in rat peripheral nervous system and innervated tissues. FEBS Lett. 262 (1990), 317–322.
3. Beckh, S., Noda, M., Lubbert, H., Numa, S., Differential regulation of three sodium channel messenger RNAs in the rat central nervous system during development. EMBO J. 8 (1989), 3611–3616.
4. Bough, K.J., Rho, J.M., Anticonvulsant mechanisms of the ketogenic diet. Epilepsia 48 (2007), 43–58.
5. Brysch, W., Creutzfeldt, O.D., Luno, K., Schlingensiepen, R., Schlingensiepen, K.H., Regional and temporal expression of sodium channel messenger RNAs in the rat brain during development. Exp. Brain Res. 86 (1991), 562–567.
6. Castello, A., Fischer, B., Eichelbaum, K., Horos, R., Beckmann, B.M., Strein, C., et al. Insights into RNA biology from an atlas of mammalian mRNA-binding proteins. Cell 149 (2012), 1393–1406.
7. Catterall, W.A., From ionic currents to molecular mechanisms: the structure and function of voltage-gated sodium channels. Neuron 26 (2000), 13–25.
8. Catterall, W.A., Kalume, F., Oakley, J.C., NaV1.1 channels and epilepsy. J. Physiol. 588 (2010), 1849–1859.
9. Cheah, C.S., Yu, F.H., Westenbroek, R.E., Kalume, F.K., Oakley, J.C., Potter, G.B., et al. Specific deletion of NaV1.1 sodium channels in inhibitory interneurons causes seizures and premature death in a mouse model of Dravet syndrome. Proc. Natl. Acad. Sci. U. S. A. 109 (2012), 14646–14651.
10. Chen, C., Westenbroek, R.E., Xu, X., Edwards, C.A., Sorenson, D.R., Chen, Y., et al. Mice lacking sodium channel beta1 subunits display defects in neuronal excitability, sodium channel expression, and nodal architecture. J. Neurosci. 24 (2004), 4030–4042.
11. Choudhary, S., De, B.P., Banerjee, A.K., Specific phosphorylated forms of glyceraldehyde 3-phosphate dehydrogenase associate with human parainfluenza virus type 3 and inhibit viral transcription in vitro. J. Virol. 74 (2000), 3634–3641.
12. Cullingford, T.E., Eagles, D.A., Sato, H., The ketogenic diet upregulates expression of the gene encoding the key ketogenic enzyme mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase in rat brain. Epilepsy Res. 49 (2002), 99–107.
13. Cummins, T.R., Aglieco, F., Renganathan, M., Herzog, R.I., Dib-Hajj, S.D., Waxman, S.G., Nav1.3 sodium channels: rapid repriming and slow closed-state inactivation display quantitative differences after expression in a mammalian cell line and in spinal sensory neurons. J. Neurosci. 21 (2001), 5952–5961.
14. Fejerman, N., Caraballo, R., Cersosimo, R., Ketogenic diet in patients with Dravet syndrome and myoclonic epilepsies in infancy and early childhood. Adv. Neurol. 95 (2005), 299–305.
15. Gong, B., Rhodes, K.J., Bekele-Arcuri, Z., Trimmer, J.S., Type I and type II Na(+) channel alpha-subunit polypeptides exhibit distinct spatial and temporal patterning, and association with auxiliary subunits in rat brain. J. Comp. Neurol. 412 (1999), 342–352.
16. Guo, F., Yu, N., Cai, J.Q., Quinn, T., Zong, Z.H., Zeng, Y.J., et al. Voltage-gated sodium channel Nav1.1, Nav1.3 and beta1 subunit were up-regulated in the hippocampus of spontaneously epileptic rat. Brain Res. Bull. 75 (2008), 179–187.
17. Hartman, A.L., Gasior, M., Vining, E.P., Rogawski, M.A., The neuropharmacology of the ketogenic diet. Pediatr. Neurol. 36 (2007), 281–292.
18. Jensen, F.E., Acute and chronic effects of seizures in the developing brain: experimental models. Epilepsia 40:Suppl. l (1999), S51–S58 discussion S64–6.
19. King, D.C., Taylor, J., Elnitski, L., Chiaromonte, F., Miller, W., Hardison, R.C., Evaluation of regulatory potential and conservation scores for detecting cis-regulatory modules in aligned mammalian genome sequences. Genome Res. 15 (2005), 1051–1060.
20. Kondo, S., Kubota, S., Mukudai, Y., Nishida, T., Yoshihama, Y., Shirota, T., et al. Binding of glyceraldehyde-3-phosphate dehydrogenase to the cis-acting element of structure-anchored repression in ccn2 mRNA. Biochem. Biophys. Res. Commun. 405 (2011), 382–387.
21. Laeger, T., Pohland, R., Metges, C.C., Kuhla, B., The ketone body beta-hydroxybutyric acid influences agouti-related peptide expression via AMP-activated protein kinase in hypothalamic GT1-7 cells. J. Endocrinol. 213 (2012), 193–203.
22. Laschet, J.J., Kurcewicz, I., Minier, F., Trottier, S., Khallou-Laschet, J., Louvel, J., et al. Dysfunction of GABAA receptor glycolysis-dependent modulation in human partial epilepsy. Proc. Natl. Acad. Sci. U. S. A. 104 (2007), 3472–3477.
23. Laschet, J.J., Minier, F., Kurcewicz, I., Bureau, M.H., Trottier, S., Jeanneteau, F., et al. Glyceraldehyde-3-phosphate dehydrogenase is a GABAA receptor kinase linking glycolysis to neuronal inhibition. J. Neurosci. 24 (2004), 7614–7622.
24. Li, H.J., Wan, R.P., Tang, L.J., Liu, S.J., Zhao, Q.H., Gao, M.M., et al. Alteration of Scn3a expression is mediated via CpG methylation and MBD2 in mouse hippocampus during postnatal development and seizure condition. Biochim. Biophys. Acta 1849 (2015), 1–9.
25. Liang, L.P., Patel, M., Seizure-induced changes in mitochondrial redox status. Free Radic. Biol. Med. 40 (2006), 316–322.
26. Lindgreen, S., Umu, S.U., Lai, A.S., Eldai, H., Liu, W., McGimpsey, S., et al. Robust identification of noncoding RNA from transcriptomes requires phylogenetically-informed sampling. PLoS Comput. Biol., 10, 2014, e1003907.
27. Lopreato, G.F., Lu, Y., Southwell, A., Atkinson, N.S., Hillis, D.M., Wilcox, T.P., et al. Evolution and divergence of sodium channel genes in vertebrates. Proc. Natl. Acad. Sci. U. S. A. 98 (2001), 7588–7592.
28. Lusardi, T.A., Akula, K.K., Coffman, S.Q., Ruskin, D.N., Masino, S.A., Boison, D., Ketogenic diet prevents epileptogenesis and disease progression in adult mice and rats. Neuropharmacology 99 (2015), 500–509.
29. McNally, M.A., Hartman, A.L., Ketone bodies in epilepsy. J. Neurochem. 121 (2012), 28–35.
30. Meisler, M.H., Kearney, J.A., Sodium channel mutations in epilepsy and other neurological disorders. J. Clin. Invest 115 (2005), 2010–2017.
31. Nabbout, R., Copioli, C., Chipaux, M., Chemaly, N., Desguerre, I., Dulac, O., et al. Ketogenic diet also benefits Dravet syndrome patients receiving stiripentol: a prospective pilot study. Epilepsia 52 (2011), e54–e57.
32. Nagy, E., Rigby, W.F., Glyceraldehyde-3-phosphate dehydrogenase selectively binds AU-rich RNA in the NAD(+)-binding region (Rossmann fold). J. Biol. Chem. 270 (1995), 2755–2763.
33. Nakayama, T., Ogiwara, I., Ito, K., Kaneda, M., Mazaki, E., Osaka, H., et al. Deletions of SCN1A 5’ genomic region with promoter activity in Dravet syndrome. Hum. Mutat. 31 (2010), 820–829.
34. Nicholls, C., Li, H., Liu, J.P., GAPDH: a common enzyme with uncommon functions. Clin. Exp. Pharmacol. Physiol. 39 (2012), 674–679.
35. Pierce, A., Mirzaei, H., Muller, F., De Waal, E., Taylor, A.B., Leonard, S., et al. GAPDH is conformationally and functionally altered in association with oxidative stress in mouse models of amyotrophic lateral sclerosis. J. Mol. Biol. 382 (2008), 1195–1210.
36. Plummer, N.W., Meisler, M.H., Evolution and diversity of mammalian sodium channel genes. Genomics 57 (1999), 323–331.
37. Rodriguez-Pascual, F., Redondo-Horcajo, M., Magan-Marchal, N., Lagares, D., Martinez-Ruiz, A., Kleinert, H., et al. Glyceraldehyde-3-phosphate dehydrogenase regulates endothelin-1 expression by a novel, redox-sensitive mechanism involving mRNA stability. Mol. Cell Biol. 28 (2008), 7139–7155.
38. Sirover, M.A., Subcellular dynamics of multifunctional protein regulation: mechanisms of GAPDH intracellular translocation. J. Cell Biochem. 113 (2012), 2193–2200.
39. Stafford, P., Abdelwahab, M.G., Kim do, Y., Preul, M.C., Rho, J.M., Scheck, A.C., The ketogenic diet reverses gene expression patterns and reduces reactive oxygen species levels when used as an adjuvant therapy for glioma. Nutr. Metab. (Lond), 7, 2010, 74.
40. Suzuki, Y., Takahashi, H., Fukuda, M., Hino, H., Kobayashi, K., Tanaka, J., et al. Beta-hydroxybutyrate alters GABA-transaminase activity in cultured astrocytes. Brain Res. 1268 (2009), 17–23.
41. Thiele, E.A., Assessing the efficacy of antiepileptic treatments: the ketogenic diet. Epilepsia 44:Suppl. 7 (2003), 26–29.
42. Tristan, C., Shahani, N., Sedlak, T.W., Sawa, A., The diverse functions of GAPDH: views from different subcellular compartments. Cell Signal 23 (2011), 317–323.
43. Whitaker, W.R., Clare, J.J., Powell, A.J., Chen, Y.H., Faull, R.L., Emson, P.C., Distribution of voltage-gated sodium channel alpha-subunit and beta-subunit mRNAs in human hippocampal formation, cortex, and cerebellum. J. Comp. Neurol. 422 (2000), 123–139.
44. Whitaker, W.R., Faull, R.L., Waldvogel, H.J., Plumpton, C.J., Emson, P.C., Clare, J.J., Comparative distribution of voltage-gated sodium channel proteins in human brain. Brain Res. Mol. Brain Res. 88 (2001), 37–53.
45. White, M.R., Garcin, E.D., The Sweet Side of RNA Regulation: Glyceraldehyde-3-Phosphate Dehydrogenase as a Noncanonical RNA-Binding Protein. 7, 2016, Wiley Interdiscip Rev RNA, 53–70.
46. Wierschke, S., Gigout, S., Horn, P., Lehmann, T.N., Dehnicke, C., Brauer, A.U., et al. Evaluating reference genes to normalize gene expression in human epileptogenic brain tissues. Biochem. Biophys. Res. Commun. 403 (2010), 385–390.
47. Woolf, E.C., Curley, K.L., Liu, Q., Turner, G.H., Charlton, J.A., Preul, M.C., et al. The ketogenic diet alters the hypoxic response and affects expression of proteins associated with angiogenesis, invasive potential and vascular permeability in a mouse glioma model. PLoS One, 10, 2015 e0130357.
48. Yu, F.H., Mantegazza, M., Westenbroek, R.E., Robbins, C.A., Kalume, F., Burton, K.A., et al. Reduced sodium current in GABAergic interneurons in a mouse model of severe myoclonic epilepsy in infancy. Nat. Neurosci. 9 (2006), 1142–1149.
49. Yu, S., Li, S., Shu, H., Zhang, C., He, J., Fan, X., et al. Upregulated expression of voltage-gated sodium channel Nav1.3 in cortical lesions of patients with focal cortical dysplasia type IIb. Neuroreport 23 (2012), 407–411.
50. Zeng, T., Dong, Z.F., Liu, S.J., Wan, R.P., Tang, L.J., Liu, T., et al. A novel variant in the 3’ UTR of human SCN1A gene from a patient with Dravet syndrome decreases mRNA stability mediated by GAPDH's binding. Hum. Genet. 133 (2014), 801–811.
51. Zhou, Y., Yi, X., Stoffer, J.B., Bonafe, N., Gilmore-Hebert, M., McAlpine, J., et al. The multifunctional protein glyceraldehyde-3-phosphate dehydrogenase is both regulated and controls colony-stimulating factor-1 messenger RNA stability in ovarian cancer. Mol. Cancer Res. 6 (2008), 1375–1384.